Heath-related quality of life in Spanish breast cancer patients: a systematic review

María Concepción Delgado-Sanz, María José García-Mendizábal, Marina Pollán, Maria João Forjaz, Gonzalo López-Abente, Nuria Aragonés, Beatriz Pérez-Gómez, María Concepción Delgado-Sanz, María José García-Mendizábal, Marina Pollán, Maria João Forjaz, Gonzalo López-Abente, Nuria Aragonés, Beatriz Pérez-Gómez

Abstract

Background: Breast cancer is one of the oncological diseases in which health-related quality of life (HRQL) has been most studied. This is mainly due to its high incidence and survival. This paper seeks to: review published research into HRQL among women with breast cancer in Spain; analyse the characteristics of these studies; and describe the instruments used and main results reported.

Methods: The databases consulted were MEDLINE, EMBASE, PsycINFO, Dialnet, IBECS, CUIDEN, ISOC and LILACS. The inclusion criteria required studies to: 1) include Spanish patients, and a breakdown of results where other types of tumours and/or women from other countries were also included; and, 2) furnish original data and measure HRQL using a purpose-designed questionnaire. The methodological quality of studies was assessed.

Results: Spain ranked midway in the European Union in terms of the number of studies conducted on the HRQL of breast cancer patients. Of the total of 133 papers published from 1993 to 2009, 25 met the inclusion criteria. Among them, only 12 were considered as having good or excellent quality. A total of 2236 women participated in the studies analysed. In descending order of frequency, the questionnaires used were the EORTC, FACT-B, QL-CA-Afex, SF-12, FLIC, RSCL and CCV. Five papers focused on validation or adaptation of questionnaires. Most papers examined HRQL in terms of type of treatment. Few differences were detected by type of chemotherapy, with the single exception of worse results among younger women treated with radiotherapy. In the short term, better results were reported for all HRQL components by women undergoing conservative rather than radical surgery. Presence of lymphedema was associated with worse HRQL. Three studies assessed differences in HRQL by patients' psychological traits. Psychosocial disorder and level of depression and anxiety, regardless of treatment or disease stage, worsened HRQL. In addition, there was a positive effect among patients who reported having a "fighting spirit" and using "denial" as a defence mechanism. One study found that breast cancer patients scored worse than did healthy women on almost all SF-12 scales.

Conclusion: Research into health-related quality of life of breast-cancer patients is a little developed field in Spain.

Figures

Figure 1
Figure 1
Results of the literature search made for each European Union country in PubMed and PsycINFO. References identified in the PubMed and PsycINFO databases in European Union countries, using "Breast cancer", "Quality of life" and country name as descriptors.
Figure 2
Figure 2
Flow chart of process of systematic literature search. Flow chart of systematic search and review process conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement criteria.

References

    1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592. doi: 10.1093/annonc/mdl498.
    1. Ganz PA, Goodwin PJ. In: Outcomes Assessment in Cancer. Measures, Methods, and Applications. 1. Lipscomb J, Gotay CC, Snyder C, editor. Cambridge: Cambridge University Press; 2005. Quality of life in breast cancer - what have we learned and where do we go from here? pp. 93–125.
    1. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32. doi: 10.1186/1756-9966-27-32.
    1. Ebrahim S. Clinical and Public-Health Perspectives and Applications of Health-Related Quality-Of-Life Measurement. Soc Sci Med. 1995;41:1383–1394. doi: 10.1016/0277-9536(95)00116-O.
    1. Osoba D. Lessons Learned from Measuring Health-Related Quality-Of-Life in Oncology. J Clin Oncol. 1994;12:608–616.
    1. Die Trill M, Die Goyanes A. In: Psico-Oncología. Die Trill M, editor. Madrid: Aula de Estudios Sanitarios; 2003. El cáncer de mama; pp. 165–184.
    1. Rowland JH, Massie MJ. In: Psycho-oncology. Holland JC, editor. New York: Oxford University Press; 1998. Breast Cancer; pp. 380–401.
    1. Ferrans CE. In: Outcomes Assessment in Cancer. Measures, Methods, and Applications. 1. Lipscomb J, Gotay CC, Snyder C, editor. Cambridge: Cambridge University Press; 2005. Definitions and conceptual models of quality of life; pp. 14–30.
    1. Erickson P. In: Outcomes Assessment in Cancer. Measures, Methods, and Applications. 1. Lipscomb J, Gotay CC, Snyder C, editor. Cambridge: Cambridge University Press; 2005. Assessing health status and quality of life of cancer patients: the use of general instruments; pp. 31–68.
    1. Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J, Sanchez-Perez MJ, Chirlaque MD, Larranaga N, Martinez-Cobo R, Tobalina MC, Vidal E, Marcos-Gragera R, Mateos A, Garau I, Rojas-Martin MD, Jimenez R, Torrella-Ramos A, Perucha J, Perez-de Rada ME, Gonzalez S, Rabanaque MJ, Borras J, Navarro C, Hernandez E, Izquierdo A, Lopez-Abente G, Martinez C. Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst. 2009;101:1584–1591. doi: 10.1093/jnci/djp358.
    1. Pollán M, García-Mendizábal MJ, Pérez-Gómez B, Aragonés N, Lope V, Pastor R, Ramis R, Fernández P, García-Pérez J, Vidal E, Boldo E, Pérdomo S, López-Abente G. Situación epidemiológica del cáncer de mama en España. Psicooncología. 2007;4:231–248.
    1. Cabanes A, Vidal E, Perez-Gomez B, Aragones N, Lopez-Abente G, Pollan M. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol. 2009;33:169–175. doi: 10.1016/j.canep.2009.08.010.
    1. Cabanes A, Vidal E, Aragones N, Perez-Gomez B, Pollan M, Lope V, Lopez-Abente G. Cancer mortality trends in Spain: 1980-2007. Ann Oncol. 2010;21:iii14–iii20. doi: 10.1093/annonc/mdq089.
    1. Chirlaque MD, Salmerón D, Ardanaz E, Galceran J, Martínez R, Marcos-Gragera R, Sacristán A, Sánchez M, Mateos A, Torrella A, Capocaccia R, Navarro C. Cancer survival in Spain: estimate for nine major cancers. Ann Oncol. 2010;21:iii21–iii29. doi: 10.1093/annonc/mdq082.
    1. Mols F, Denollet J. Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes. 2010;8:9. doi: 10.1186/1477-7525-8-9.
    1. Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–1488. doi: 10.1093/jnci/djp336.
    1. Toledo M, Barreto MP, Pascual A, Ferrero J. Adaptación del cuestionario de calidad de vida de la E.O.R.T.C. para cáncer de mama. Rev Psicol Salud. 1993;5:29–45.
    1. Font A. Cáncer y calidad de vida. Anu Psicol. 1994;61:41–50.
    1. Sprangers MA, Groenvold M, Arraras JI, Franklin J, Te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–2768.
    1. Arraras JI, Garrido E, Pruja E, Marcos M, Tejedor M, Arias F. El Cuestionario de Calidad de Vida de la EORTC QLQ-C30 (Version 2.0). Estudio psicométrico con pacientes con cáncer de mama. Clin Salud. 2000;11:329–349.
    1. Arraras JI. El cuestionario de calidad de vida para cáncer de mama de la EORTC, QLQ-BR23: Estudio psicométrico con una muestra española. Psicol Conduct. 2001;9:81–97.
    1. Ruiz MA, Garde S, Ascunce N, Del Moral A. Intervención psicológica en pacientes con cáncer de mama. An Sis San Navarra 1998. 1998;21:119–124.
    1. Sebastián J, Bueno MJ, Mateos N, García P. Evaluación de un programa de intervención sobre cáncer de mama. Bol Psicol. 1999;65:53–73.
    1. Font A, Rodríguez E. Eficacia de la terapia de grupo en cáncer de mama: Variaciones de la calidad de vida. Psicooncología. 2004;1:67–86.
    1. Sánchez N, Torres A, Camprubí N, Vidal A, Salamero M. Factores predictores del abandono de la intervención psicológica grupal en una muestra de pacientes con cáncer de mama. Psicooncología. 2005;2:21–32.
    1. Páez MB, Luciano C, Gutiérrez O. Tratamiento psicológico para el afrontamiento del cáncer de mama. Estudio comparativo entre estrategias de aceptación y de control cognitivo. Psicooncología. 2007;4:75–95.
    1. Bellver A. Eficacia de la terapia grupal en la calidad de vida y el estado emocional en mujeres con cáncer de mama. Psicooncología. 2007;4:133–142.
    1. Manos D, Sebastian J, Mateos N, Bueno MJ. Results of a multi-componential psychosocial intervention programme for women with early-stage breast cancer in Spain: quality of life and mental adjustment. Eur J Cancer Care (Engl) 2009;18:295–305. doi: 10.1111/j.1365-2354.2008.00978.x.
    1. Blasco T, Rodríguez E. Calidad de vida y bienestar en pacientes de cáncer que reciben quimioterapia a altas dosis: Un estudio preliminar. Clin Salud. 1995;6:331–340.
    1. Cagigal-Rodríguez JA, Velasco Sánchez MDM. Valoración subjetiva de la calidad de vida en pacientes con cáncer de mama metastásico durante el tratamiento con quimioterapia. Clin Salud. 1995;6:83–92.
    1. Arraras JI, Manterola A, Domínguez MA, Arias F, Villafranca E, Romero P, Martínez E, Illarramendi JJ, Salgado E. Impact of radiotherapy on the quality of life of elderly patients with localized breast cancer. A prospective study. Clin Transl Oncol. 2008;10:498–504. doi: 10.1007/s12094-008-0239-0.
    1. Toledo M. Cirugía del cáncer de mama y valoración de la calidad de vida global. Rev Psicol Univ Tarracon. 1996;18:17–37.
    1. Arraras JI, Illarramendi JJ, Tejedor M. Quality of life in Spanish breast cancer patients assessed with the EORTC questionnaires. Rev Oncología. 2001;3:100–106.
    1. Arraras J, Illarramendi J, Manterola A, Tejedor M, Vera R, Valerdi J, Domínguez M. Evaluación de la calidad de vida a largo plazo en pacientes con cáncer de mama en estadios iniciales mediante los cuestionarios de la EORTC. Rev Clin Esp. 2003;203:577–581. doi: 10.1157/13053726.
    1. Herrero F, San Juan AF, Fleck SJ, Balmer J, Perez M, Canete S, Earnest CP, Foster C, Lucia A. Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med. 2006;27:573–580. doi: 10.1055/s-2005-865848.
    1. Condón MJ, González MA, Tamayo R, Martínez A. Calidad de vida en pacientes con y sin linfedema después del tratamiento del cáncer de mama. Implicaciones en la rehabilitación. Rehabilitación (Madr) 2000;34:248–253.
    1. Yélamos C, Montesinos F, Eguino A, Fernández B, González A, García M, Fernández AI. Impacto del linfedema en la calidad de vida de las mujeres con cáncer de mama. Psicooncología. 2007;4:143–163.
    1. Ferrero J, Barreto M, Toledo M. Mental adjustment to cancer and quality of life in breast cancer patients: An exploratory study. Psychooncology. 1994;3:223–232. doi: 10.1002/pon.2960030309.
    1. Ferrero-Berlanga J, Toledo M, Barreto MP. Evaluación cognitiva y afrontamiento como predictores del bienestar futuro de las pacientes con cáncer de mama. Rev Latinoam Psicol. 1995;27:87–102.
    1. Manos D, Sebastián J, Bueno MJ, Mateos N, De la Torre A. Body image in relation to self-esteem in a sample of Spanish women with early-stage breast cancer. Psicooncología. 2005;2:103–116.
    1. Cervera S, Aubá E. Calidad de vida y dinámica familiar tras el diagnostico de cáncer de mama. Bol Psicol. 2005;85:7–29.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E, Valerdi J. The EORTC QLQ-C30 (Version 3.0) Quality of Life questionnaire: Validation study for Spain with head and neck cancer patients. Psychooncology. 2002;11:249–256. doi: 10.1002/pon.555.
    1. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579.
    1. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997;15:974–986.
    1. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol. 1984;2:472–483.
    1. Agra Y, Badia X. Spanish version of the Rotterdam Symptom Check List: cross-cultural adaptation and preliminary validity in a sample of terminal cancer patients. Psychooncology. 1998;7:229–239. doi: 10.1002/(SICI)1099-1611(199805/06)7:3<229::AID-PON302>;2-R.
    1. Ruiz M. Design and validation of the "Quality of Life Questionnaire" (Cuestionario de Calidad de Vida, CCV) Eur J Psychol Assess. 1993;9:19–32.
    1. Perry S, Kowalski T, Chang C. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes. 2007;5:24. doi: 10.1186/1477-7525-5-24.
    1. Martin M, Mahillo E, Llombart-Cussac A, Lluch A, Munarriz B, Pastor M, Alba E, Ruiz A, Anton A, Bermejo B. The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain. Clin Transl Oncol. 2006;8:508–518. doi: 10.1007/s12094-006-0051-7.
    1. Dorval M, Maunsell E, Deschenes L, Brisson J. Type of mastectomy and quality of life for long term breast carcinoma survivors. Cancer. 1998;83:2130–2138. doi: 10.1002/(SICI)1097-0142(19981115)83:10<2130::AID-CNCR11>;2-8.
    1. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10:223–231. doi: 10.1111/j.1075-122X.2004.21323.x.
    1. Shimozuma K, Ganz PA, Petersen L, Hirji K. Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat. 1999;56:45–57. doi: 10.1023/A:1006214830854.
    1. Hopwood P, Haviland J, Mills J, Sumo G, Bliss M. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial) Breast. 2007;16:241–251. doi: 10.1016/j.breast.2006.11.003.
    1. Meneses KD, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA. Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum. 2007;34:1007–1016. doi: 10.1188/07.ONF.1007-1016.
    1. Gordon LG, Battistutta D, Scuffham P, Tweeddale M, Newman B. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat. 2005;93:217–226. doi: 10.1007/s10549-005-5151-5.
    1. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA. Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol. 2003;21:4027–4033. doi: 10.1200/JCO.2003.08.097.
    1. Longman AJ, Braden CJ, Mishel MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncol Nurs Forum. 1999;26:909–915.
    1. Badger TA, Braden CJ, Mishel MH, Longman A. Depression burden, psychological adjustment, and quality of life in women with breast cancer: patterns over time. Res Nurs Health. 2004;27:19–28. doi: 10.1002/nur.20002.
    1. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184–187. doi: 10.1016/S0002-9610(99)00008-2.
    1. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13:904–911. doi: 10.1007/s00520-005-0810-y.
    1. Gelber RD, Goldhirsch A, Cavalli F. Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer. Ann Intern Med. 1991;114:621–628.
    1. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M. et al.Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005;352:2302–2313. doi: 10.1056/NEJMoa043681.
    1. Martin M, Lluch A, Segui MA, Ruiz A, Ramos M, Adrover E, Rodriguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacon C, Roset M, Antón A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, López-Vega JM, Muñoz M, Mel JR. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Ann Oncol. 2006;17:1205–1212. doi: 10.1093/annonc/mdl135.
    1. Blasco T, Inglés N. Calidad de vida y adaptación a la enfermedad en pacientes de cáncer durante el tratamiento de quimioterapia. Anu Psicol. 1997;72:81–90.
    1. Padierna C, Fernández C, Amigo I, Gracia JM, Fernández R, Peláez I, Pérez M. Estudio longitudinal de los parámetros de calidad de vida en pacientes oncológicos. Psicooncología. 2004;1:191–204.
    1. Terol MC, López-Roig S, Rodríguez-Marín J, Pastor MA, Mora M, Martín-Aragón M, Leyda-Menéndez JI, Neipp MC, Lizón J. Diferencias en la calidad de vida: Un estudio longitudinal de pacientes de cáncer recibiendo tratamiento de quimioterapia. An Psicol. 2000;16:111–122.
    1. Leon-Pizarro C, Gich I, Barthe E, Rovirosa A, Farrus B, Casas F, Verger E, Biete A, Craven-Bartle J, Sierra J, Arcusa A. A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology. 2007;16:971–979. doi: 10.1002/pon.1171.
    1. Espantoso R, Fernández C, Padierna C, Amigo I, Villoria E, Gracia JM, Fernández R, Peláez I. Calidad de vida en pacientes oncológicos un año después de finalizado el tratamiento. Psicooncología. 2007;4:43–57.
    1. García Lumbreras S, Blasco T. Características de la sexualidad en mujeres con cáncer de mama. Psicooncología. 2008;5:155–170.
    1. Bárez M, Blasco T, Fernández-Castro J, Viladrich C. Perceived control and psychological distress in women with breast cancer: a longitudinal study. J Behav Med. 2009;32:187–196.
    1. Schwartzmann L. Calidad de vida relacionada con la salud: Aspectos conceptuales. Cienc Enferm. 2003;9:9–21. doi: 10.4067/S0717-95532003000200002.
    1. Mianyo MCS, Hartz ZMA, Buss PM. Qualidade de vida e saúde: um debate necessário. Cien Saude Colet. 2000;5:7–18.
    1. Forjaz MJ, Guarnaccia CA. A comparison of Portuguese and American patients with hematological malignancies: a cross-cultural survey of health-related quality of life. Psychooncology. 2001;10:251–258. doi: 10.1002/pon.522.abs.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren